Improved detection of advanced oxidation protein products in plasma

被引:205
|
作者
Hanasand, Marita [1 ,2 ]
Omdal, Roald [2 ,3 ]
Norheim, Katrine B. [2 ]
Goransson, Lasse G. [2 ,3 ]
Brede, Cato [1 ]
Jonsson, Grete [1 ]
机构
[1] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway
[2] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, N-4068 Stavanger, Norway
[3] Univ Bergen, Inst Internal Med, N-5020 Bergen, Norway
关键词
Advanced oxidation protein products; Protein oxidation; Lipoprotein solubility; Spectrophotometry; Method validation; Chronic inflammation; FREE-RADICALS; STRESS; MYELOPEROXIDASE; ANTIOXIDANTS; BIOMARKERS; MARKER; DAMAGE; ASSAY;
D O I
10.1016/j.cca.2012.01.038
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Oxidative stress has been associated with many diseases and can among others be assessed as increased levels of advanced oxidation protein products (AOPP). Current AOPP methods suffer from poor reproducibility and accuracy due to precipitation of lipids in plasma samples. We therefore aimed to develop a robust method in which plasma lipids are solubilized. Methods: Plasma was diluted with citric acid, and AOPP measured as absorbance at 340 nm. The method was optimized and validated, and then used to analyze AOPP levels in plasma from healthy control subjects (HC), and in three patients groups; chronic kidney disease (CKD), primary Sjogren's Syndrome (pSS) and systemic lupus erythematosus (SLE). Results: AOPP was detected with improved precision compared to established methods where lipids precipitate. Within- and between days variations were less than 1.4% and 22%, respectively. A control chart was established and the long-term reproducibility followed over six months. Conclusions: This improved method detects plasma AOPP with significantly better reproducibility and accuracy compared to previously reported methods. Solubilization of plasma lipids before spectrophotometric measure of AOPP levels is novel. It prevents both loss of lipoproteins due to precipitation and overestimation as a result of light scattering. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 50 条
  • [41] An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study
    Gonzalez, Elena
    Bajo, Maria-Auxiliadora
    Carrero, Juan J.
    Lindholm, Bengt
    Grande, Cristina
    Sanchez-Villanueva, Rafael
    Del Peso, Gloria
    Diaz-Almiron, Mariana
    Iglesias, Pedro
    Diez, Juan J.
    Selgas, Rafael
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [42] Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases
    Rasool, Mahmood
    Malik, Arif
    Butt, Tariq Tahir
    Ashraf, Muhammad Abdul Basit
    Rasool, Rabia
    Zahid, Ayesha
    Waquar, Sulayman
    Asif, Muhammad
    Zaheer, Ahmad
    Jabbar, Abdul
    Zain, Maryam
    Mehmood, Asim
    Qaisrani, Tahira Batool
    Malik, Imran Riaz
    Khan, Sami Ullah
    Mirza, Zeenat
    Haque, Absarul
    Al-Qahtani, Mohammed Hussein
    Karim, Sajjad
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2019, 26 (02) : 334 - 339
  • [43] Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus
    Kalousová, M
    Skrha, J
    Zima, T
    PHYSIOLOGICAL RESEARCH, 2002, 51 (06) : 597 - 604
  • [44] Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome
    Baskol, Gulden
    Korkmaz, Selda
    Erdem, Feray
    Caniklioglu, Aysen
    Kocyigit, Merve
    Aksu, Murat
    SLEEP MEDICINE, 2012, 13 (04) : 414 - 418
  • [45] In Vitro Oxidation of Fibrinogen Promotes Functional Alterations and Formation of Advanced Oxidation Protein Products, an Inflammation Mediator
    Torbitz, Vanessa Dorneles
    Bochi, Guilherme Vargas
    Mainardi de Carvalho, Jose Antonio
    Vaucher, Rodrigo de Almeida
    Paz da Silva, Jose Edson
    Moresco, Rafael Noal
    INFLAMMATION, 2015, 38 (03) : 1201 - 1206
  • [46] Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors
    Valli, Alessandro
    Suliman, Mohamed E.
    Meert, Natalie
    Vanholder, Raymond
    Lindholm, Bengt
    Stenvinkel, Peter
    Watanabe, Makoto
    Barany, Peter
    Alvestrand, Anders
    Anderstam, Bjorn
    CLINICA CHIMICA ACTA, 2007, 379 (1-2) : 87 - 94
  • [47] Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease
    Aldred, Sarah
    Bennett, Stuart
    Mecocci, Patrizia
    CLINICAL BIOCHEMISTRY, 2010, 43 (03) : 267 - 271
  • [48] Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing
    Komosinska-Vassev, Katarzyna
    Olczyk, Pawel
    Winsz-Szczotka, Katarzyna
    Kuznik-Trocha, Kornelia
    Klimek, Katarzyna
    Olczyk, Krystyna
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (03) : 557 - 563
  • [49] Advanced Oxidation Protein Products and Advanced Glycation End Products in Children and Adolescents With Chronic Renal Insufficiency
    Sebekova, Katarina
    Klenovicsova, Kristina
    Ferenczova, Juliana
    Hedvig, Juraj
    Podracka, L'udmila
    Heidland, August
    JOURNAL OF RENAL NUTRITION, 2012, 22 (01) : 143 - 148
  • [50] Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury
    Yamamoto, Yasuhiko
    Yamamoto, Hiroshi
    KIDNEY INTERNATIONAL, 2012, 82 (07) : 733 - 735